Back to search results

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Abroad (travel likely)Recruiting

Conditions

Metabolic Syndrome X · Fatty Liver · MASH - Metabolic Dysfunction-Associated Steatohepatitis · MASLD · NASH (Non-Alcoholic Steatohepatitis) · Steatosis, Liver · NAFLD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Hospital Angers, Angers, France

    Contact: Study coordinator (Jerome Boursier, MD, PhD) · jeboursier@chu-angers.fr · +33 2 41 35 31 42
    Contact: Principal Investigator (Jerome Boursier, MD PhD)
    Christophe Aubé, MD, PhD (Sub-investigator)

  • Beaujon University Hospital, Clichy, France

    Contact: Study coordinator (Laurent Castera, MD, PhD) · laurent.castera@aphp.fr · +33 1 40 87 55 24
    Contact: Principal Investigator (Laurent Castera, MD, PhD)
    Valerie Vilgrain, MD, PhD (Sub-investigator)
    Marco Dioguardi Burgio, MD (Sub-investigator)
    Hélène Fontaine, MD (Sub-investigator)

  • Pitie Salpetriere University Hospital, Paris, France

    Contact: Study coordinator (Raluca Pais, MD) · raluca.pais@aphp.fr · +33 1 42 16 10 34
    Contact: Principal Investigator (Raluca Pais, MD)
    Olivier Lucidarme, MD, PhD (Sub-investigator)
    Mathilde Wagner, MD, PhD (Sub-investigator)
Study leads

  • Claude Cohen-Bacrie

    Study Director

    E-Scopics

  • Jerome Boursier, MD, PhD

    Study Chair

    University Hospital, Angers

View source on ClinicalTrials.gov(opens in a new tab)